Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics in acute lymphoblastic leukemia.

Seminars in hematology - 1 Jan 2009

Cheok Meyling H, Pottier Nicolas, Kager Leo, Evans William E

Abstract excerpt

Progress in the treatment of acute lymphoblastic leukemia (ALL) in children has been remarkable, from a disease being lethal four decades ago to current cure rates exceeding 80%. This exemplary progress is largely due to the optimization of existing treatment modalities rather than the discovery of new antileukemic agents. However, despite these high cure rates, the annual number of children whose leukemia...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Child
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Computational Biology

Share to Gene Expression Profiling

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Source

Open in PubMed Open full text

Identifiers

PMID: 19100367
DOI: 10.1053/j.seminhematol.2008.09.002
PMCID: PMC2665795

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics in acute lymphoblastic leukemia.PMID 19100367Read ↗

Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Therapies on the horizon for childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.Semantic proximity Read ↗

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?Semantic proximity Read ↗

Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.Semantic proximity Read ↗

Advances in the Biology of Acute Lymphoblastic Leukemia—From Genomics to the ClinicSemantic proximity Read ↗

Genomics in acute lymphoblastic leukaemia: insights and treatment implications.Semantic proximity Read ↗

Biology, risk stratification, and therapy of pediatric acute leukemias: an update.Semantic proximity Read ↗

Novel Biomarkers and Molecular Targets in ALL.Semantic proximity Read ↗

Precision Medicine for Acute Lymphoblastic Leukemia in Children: A ReviewSemantic proximity Read ↗

Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.Semantic proximity Read ↗

Insights of Acute Lymphoblastic Leukemia with Development of Genomic Investigation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.